Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)

Clinical trial NCT06636786 · RECRUITING

Trial details

NCT number: NCT06636786
Sponsor: University of North Carolina, Chapel Hill
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Stress Reaction Acute Stress Disorder Neurocognitive Function Post-traumatic Stress

Start date: 2025-03-25
Primary completion: 2026-09-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.